Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mipomersen Extension in Familial Hypercholesterolemia
NCT00477594Phase 2Completed
- Sponsor
- Kastle Therapeutics LLC
- Start
- May 2007
- Primary completion
- Mar 2011
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 2 trial of mipomersen in familial hypercholesterolemia (FH), sponsored by Kastle Therapeutics LLC. Started May 2007; status: completed.
02
Drugs
mipomersen
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NCT00477594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00477594.